1. [MASK (Mobile Airways Sentinel Network). ARIA's comprehensive solution for mobile app for the multimorbidity of allergic rhinitis and asthma]
- Author
-
Larenas-Linnemann, Désirée, Mullol, Joaquim, Ivancevich, Juan Carlos, Antó, Josep, Cardona, Victoria, Dedeu, Toni, Rodriguez-González, Mónica, Huerta, Yunuen, Neffen, Hugo, Fuentes-Pérez, José Miguel, Rodriguez-Zagal, Eréndira, Valero, Antonio, Zernotti, Mario, Bartra, Joan, Alobid, Isam, Castillo-Vizuete, José Antonio, Dordal, Teresa, Hijano, Rafael, Picado, César, Sastre, Joaquin, Blua, Ariel Eduardo, Jares, Edgardo, Lavrut, Alberto Jorge, Máspero, Jorge, Bedolla-Barajas, Martin, Burguete, Maria, Costa, Maria Del Carmen, Dominguez-Silva, Margarita, Espinoza-Contreras, Jesús Guillermo, Gálvez-Romero, José Luis, Garcia-Cobas, Cecilia Yvonne, Garcia-Cruz, Maria de la Luz Hortensia, Hernández-Velázquez, Luiana, Luna-Pech, Jorge, Matta, Juan José, Mogica-Martinez, Maria Dolores, Rivero-Yeverino, Daniela, Ruiz-Segura, Lucy Tania, Del Rio-Navarro, Blanca, Gómez, Javier, Macias-Weinmann, Alejandra, Murray, Ruth, Onorato, Gabrielle, Laune, Daniel, Bedbrook, Anna, Bousquet, Jean, Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Vall d'Hebron University Hospital [Barcelona], IMIM-Hospital del Mar, Generalitat de Catalunya, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), and Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
- Subjects
lcsh:Immunologic diseases. Allergy ,app móvil ,m-salud ,conjuntivitis alérgica ,ARIA ,[SDV]Life Sciences [q-bio] ,m-Health ,Mobil App ,Multimorbidity ,Self Medication ,MASK-AIR ,Allergic conjunctivitis ,Mobile Applications ,Rhinitis, Allergic ,Allergic rhinitis ,Asthma ,asma ,mask-aria ,Humans ,lcsh:RC581-607 ,rinitis alérgica ,Conjunctivitis, Allergic - Abstract
International audience; The vast majority of patients with allergic rhinitis (AR) do not receive the proper management which is recommended by the guidelines, but they frequently self-medicate. MASK (Mobile Airways Sentinel Network) is an integral part of a project that is supported by the European Union againstchronic diseases and focused on active and healthy aging. MASK represents the third phase of ARIA (Allergic Rhinitis and its Impact on Asthma), in which, by using a mobile application in a smart device, the objective is to guide the patient in the control of his/her multi-morbidity, AR and/or allergic conjunctivitis (AC) and/or asthma. The mobile app Allergy Diary by MACVIA-ARIA is free and it is available for both Android and iOS platforms. After it is downloaded to the patient’s cell phone, it fi rst requests some information about the patient’s profi le, allergic pathologies and medication; afterwards, through a visual analog scale, the patient is invited to determine the degree of affectation in the nose, eyes, and bronchi, and its influence on their productivity at work / school. After analyzing the data generated by fi lling the Allergy Diary, it became clear there is a new clinical entity: allergic rhinitis+ allergic conjunctivitis +asthma, with greater effect; in addition to a high level of self-medication: in general, the patient takes medication on days when symptoms are present. The app has already been deployed in 23 countries, including several Spanish-speaking countries.; La mayor\'ia de los pacientes con rinitis alérgica no recibe el manejo idóneo, sino que se automedica. MASK (Mobile Airways Sentinel Network) forma parte integral de un proyecto apoyado por la Unión Europea contra las enfermedades crónicas y enfocado al envejecimiento activo y saludable. Constituye la tercera fase de ARIA (Allergic Rhinitis and its Impact on Asthma), en la cual mediante una aplicación móvil en un dispositivo inteligente se intenta guiar al paciente en el control de su multimorbilidad, rinitis o conjuntivitis alérgicas o asma. La aplicación Diario de Alergia por MACVIA-ARIA es gratuita y está disponible para Android e iOS. Al descargarla al celular del paciente, a este se le piden datos de su perfil, patolog\'ias alérgicas y medicación; posteriormente, mediante una escala visual analógica se le invita a determinar el grado de afectación en nariz, ojos y bronquios y su influencia sobre su productividad laboral/escolar. Con los datos del Diario de Alergia se observa que existe un nuevo patrón de presentación: rinitis alérgica + conjuntivitis alérgica + asma, con mayor afectación, as\'i como un alto nivel de automedicación: en general, el paciente toma medicación cuando presenta s\'intomas. La app se ha desplegado en 23 pa\'ises, incluyendo varios pa\'ises hispanohablantes.
- Published
- 2019
- Full Text
- View/download PDF